pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Nephrology · news · pharmadog
← back to Nephrology
News · Nephrology
282
stories
May 5, 26
Simlukafusp Alfa Regimens Show Manageable Safety and Activity But Do Not Outperform SOC in Metastatic RCC
onclive
May 5, 26
Dr McGregor on Key End Points of the STRIKE Trial of Tivozanib Plus Pembrolizumab in RCC
onclive
May 5, 26
Vertex earnings get muted investor response
biopharma dive
May 4, 26
With $97M, Latus pursues a different kind of Huntington’s gene therapy
biopharma dive
May 4, 26
What to know about hantavirus, the illness suspected in a cruise ship outbreak
stat
May 2, 26
Opinion: What do medical students think about their education?
stat
May 1, 26
‘Forever chemicals’ in baby formula? Scientists unpack FDA results
stat
Apr 30, 26
STAT+: What does Akeso’s primo plenary spot say about its survival data?
stat
Apr 30, 26
STAT+: New obesity tool aims to predict risk of 18 serious complications
stat
Apr 28, 26
Predicting consequences of new hepatitis B vaccine recs
stat
Apr 22, 26
Merck adds to pharma’s AI push; Roche details MS drug results
biopharma dive
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: VitriVax scores $87M; Ansa adds $71.5M series C
fiercebiotech
← prev
page 10 of 10
next →